Back

Clinical course and outcomes of patients with hypertrophic cardiomyopathy prior to evaluation at a comprehensive hypertrophic cardiomyopathy center

11 May 2026 (12:30 - 13:30)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease - hypertrophic cardiomyopathy (3) Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Nosheen Reza

Hospital of the University of Pennsylvania, Philadelphia (United States of America)

8 More presentations in this session

Presentation thumbnail
Comparisons in clinical outcomes for pediatric patients diagnosed with hypertrophic cardiomyopathy
Professor J. Conway (Edmonton, CA)
Abstract Slides
Presentation thumbnail
Real-world predictors of adverse outcomes in hcm: who is really at risk?
Doctor D. Ferreira (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Outcomes of patients with hypertrophic cardiomyopathy after evaluation at a comprehensive hypertrophic cardiomyopathy center
Doctor N. Reza (Philadelphia, US)
Abstract Slides
Presentation thumbnail
The burden of hypertrophic cardiomyopathy-related major adverse cardiovascular events prior to comprehensive HCM care
Doctor N. Reza (Philadelphia, US)
Abstract Slides
Presentation thumbnail
Safety and efficacy of mavacamten compared to alcohol septal ablation in hypertrophic obstructive cardiomyopathy in a retrospective real-world cohort
Doctor V. Santner (Graz, AT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in myocardial disease - hypertrophic cardiomyopathy (3)

The Event

Event poster

Heart Failure 2026

11 May 2026 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Clinical description and follow-up of adult hypertrophic cardiomyopathy patients
29 June 2021
thumbnail
Congress Presentation
Outcomes in hypertrophic obstructive cardiomyopathy patients undergoing non-cardiac surgery-a nationwide analysis
29 August 2022
thumbnail
Congress Session
Contemporary management of hypertrophic cardiomyopathy
27 August 2023
thumbnail
Congress Presentation
Six-month outcomes of a high intensity exercise programme in young patients with hypertrophic cardiomyopathy: The SAFE-HCM trial
17 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources